New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2013
14:44 EDTEMREmerson CEO Farr: Recent order trends suggest market conditions stabilizing
On Emerson's (EMR) Q1 earnings conference call, CEO David Farr said, "The pockets of growth our businesses captured were encouraging even though the level of total investment in our end markets continues to be slow. Recent order trends suggest market conditions have stabilized and may be poised for improvement, particularly in the emerging markets. Business investment remains slow and cautious globally, particularly in Europe, but there have been indications of thawing demand in certain markets." Despite the tenuous economic environment, the company expects to be on pace for record financial performance in 2013, with most of the gains coming in the first half of the year. Asia is expected to gain order growth momentum in the second quarter, especially in China and India. Also, steady demand in the near term from the continued recovery of residential end markets in U.S. is expected to drive profits. Management says the balance sheet remains strong and the near term outlook looks solid, supported by energy end market strength and a high backlog. Overall, the company says its cost structure remains well-positioned for continued sluggish demand for industrial capital goods in the near term.
News For EMR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 30, 2015
10:18 EDTEMROptions with increasing implied volatility
Subscribe for More Information
January 26, 2015
09:58 EDTEMREmerson reports 3 months end December orders down 5% to flat
Subscribe for More Information
January 22, 2015
10:03 EDTEMROn the Fly: Analyst Initiation Summary
Subscribe for More Information
10:03 EDTEMROn the Fly: Analyst Downgrade Summary
Subscribe for More Information
07:57 EDTEMREmerson downgraded at BofA/Merrill
As previously reported, BofA/Merrill downgraded Emerson to Underperform from Neutral. The firm reduced forecasts below consensus based on expectations Process organic growth will decline in 2016 and 2017 and pressure the stock multiple. Price target lowered to $62 from $66.
06:51 EDTEMREmerson downgraded to Underperform from Neutral at BofA/Merrill
Subscribe for More Information
06:33 EDTEMREmerson downgraded to Neutral from Outperform at RW Baird
Subscribe for More Information
January 21, 2015
16:12 EDTEMREmerson initiated with a Neutral at UBS
Target $62.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use